Health Care: Drugs

Mylan Inc (MYL: NASDAQ)

$46.92 n/a | n/a%
04/17/14 - 03:59 PM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 626.53M 642.93M 538.80M 345.54M
Operating Gains/Losses 0.00 0.00 48.56M 127.06M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -553.52M -354.84M -318.87M 21.86M
(Increase) Decrease in Inventories -157.06M -172.02M -220.60M -94.73M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 137.21M 81.43M 133.67M 23.02M
(Decrease) Increase In Other Current Liabilities -1.11M -49.99M 96.94M 135.06M
(Increase) Decrease In Other Working Capital 85.84M -177.13M -161.40M -227.65M
Other Non-Cash Items 539.80M 540.96M 150.05M 167.17M
Net Cash From Continuing Operations 1.11B 949.02M 720.42M 931.40M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 1.11B 949.02M 720.42M 931.40M
Sale of Property, Plant & Equipment 25.25M 16.34M 0.00 4.95M
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 8.06M 0.00 4.57M
Purchases of Property, Plant & Equipment -334.58M -305.32M -279.85M -192.79M
Acquisitions -1.26B 0.00 -80.51M -562.76M
Purchases of Short-Term Investments 0.00 -9.88M 0.00 -7.52M
Other Cash from Investing Activities -288.88M -73.43M 38.34M 28.15M
Cash Provided by Financing Activities
Net Cash From Investing Activities -1.87B -364.24M -332.04M -725.41M
Issuance of Debt 4.97B 2.04B 1.46B 2.36B
Cash Used for Financing Activities
Issuance of Capital Stock 76.17M 143.88M 67.74M 54.65M
Repayment of Long-Term Debt -3.48B -2.00B -1.64B -2.14B
Repurchase of Capital Stock -1,000.00M -999.89M -350.00M 0.00
Payment of Cash Dividends 0.00 0.00 0.00 -139.04M
Other Financing Charges, Net 122.32M 199.53M -176.54M -27.42M
Net Cash From Financing Activities 692.91M -611.52M -645.00M 100.35M
Effect of Exchange Rate Changes 10.66M 1.65M -30.38M -24.81M
Net Change in Cash & Cash Equivalents -58.68M -25.09M -287.00M 281.54M

Portfolios with MYL

Latest MYL Headlines from TheStreet

More Financial News for MYL

Press Releases for MYL

See All Press Releases

Partner Headlines for MYL

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter